Under construction – not a live service
Sign in

NCT05724953TerminatedPhase 1

Alexithymia Intervention for Suicide

Alexithymia Intervention for Suicide (ALEXIS)

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Reason given: Staff turnover and trouble with recruitment, staffing, and paying invoices.

Brief summary (registry, in English)

Suicide rates among Veterans with Serious Mental Illness (SMI) are intractably high, representing a serious public health concern and a critical target for interventions. Yet, at present available treatments offer modest benefits. Thus, there remains an urgent need to identify novel approaches to address suicide risk in this population. Previous reports have linked suicide risk with poor social functioning. Emerging evidence from basic affective neuroscience research has indicated that effective social functioning is contingent on intact emotion awareness. Consistent with these findings, individuals with SMI at risk of suicide display social functioning difficulties along with poor emotion awareness (i.e., alexithymia). Employing a proof-of-concept design, the aim of the present study is to test the feasibility and acceptability of a novel, blended psychoeducation and digital mHealth (mobile health) intervention with smartphones designed to target alexithymia and poor social functioning to reduce suicide risk in Veterans with SMI.

Status (registry)
Terminated
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
11 (actual)
First submitted
1 Feb 2023
Start date
1 Oct 2023
Primary completion date
30 Jan 2026
Lead sponsor
VA Office of Research and Development
NCT number
NCT05724953

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • have medical/neurological conditions that could interfere with study participation

Other

  • enrolled in another treatment study
  • unable/unwilling to provide a verifiable contact for emergency purposes

Who the study is looking for

  • a DSM-V diagnosis of PTSD
  • bipolar disorder
  • MDD
  • schizophrenia
  • at risk of suicide(Columbia Suicide Severity Rating Scale
  • C-SSRS >=3 or a suicide attempt in the past 5 years)
    • limited emotion awareness (Toronto Alexithymia Scale; TAS-20 >=52)
    • can understand all the study's risks and benefits

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
James J. Peters VA Medical Center, Bronx, NYThe BronxUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.